CTI BioPharma Reports Third Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to CTI BioPharma Reports Third Quarter 2020 Financial Results

CTI BioPharma (CTIC) Reports In-Line Q3 EPS

November 10, 2020 4:36 PM EST

CTI BioPharma (NASDAQ: CTIC) reported Q3 EPS of ($0.15), in-line with the analyst estimate of ($0.15).

"This past quarter we made significant progress in our pacritinib development program. We recently announced the initiation of our rolling New Drug Application (NDA) submission for pacritinib in myelofibrosis patients with... More